LEADS BIOLABS' OPAMTISTOMIG (PD-L1/4-1BB BISPECIFIC ANTIBODY) ADVANCES TO EXPANSION STAGE IN PHASE II FIRST-LINE GASTRIC CANCER STUDY

Reuters · 2d ago

Please log in to view news